Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Patanjali claims research shows success treating psoriasis using Sorogrit and Divya oil. Acharya Balkrishna highlights ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their ...

QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and ...

Researchers have found in a new study that a significant association between psoriasis severity and apical periodontitis (AP) ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

A new study published in the journal of Cureus showed that nearly three out of four psoriasis patients had dyslipidemia, ...